These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7980246)

  • 1. A reversible parkinsonian syndrome and hepatotoxcity following addition of carbamazepine to sodium valproate.
    Froomes PR; Stewart MR
    Aust N Z J Med; 1994 Aug; 24(4):413-4. PubMed ID: 7980246
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal hepatotoxicity in child on phenobarbitone and sodium valproate.
    Jacobi G; Thorbeck R; Ritz A; Janssen W; Schmidts HL
    Lancet; 1980 Mar; 1(8170):712-3. PubMed ID: 6103126
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.
    Mattson RH; Cramer JA; Collins JF
    N Engl J Med; 1992 Sep; 327(11):765-71. PubMed ID: 1298221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonian syndrome in childhood after sodium valproate administration.
    Alvarez-Gomez MJ; Vaamonde J; Narbona J; Barao M; Barona P; Brannan T; Gudin M; Ibañez R
    Clin Neuropharmacol; 1993 Oct; 16(5):451-5. PubMed ID: 8221706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fatal liver disorder during treatment with sodium valproate and carbamazepine].
    Rolland JC; Autret E; Drucker J; Grande-Ponte MC; Billard C; Laugier J; Grenier B
    Arch Fr Pediatr; 1982 Nov; 39(9):725-6. PubMed ID: 6819837
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolated increase in serum alkaline phosphatase with sodium valproate therapy.
    McPherson GS; Jani BR
    Ann Pharmacother; 1995 May; 29(5):539. PubMed ID: 7655142
    [No Abstract]   [Full Text] [Related]  

  • 7. [Parkinsonism induced by sodium valproate].
    del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V
    Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute psychosis with carbamazepine and sodium valproate.
    McKee RJ; Larkin JG; Brodie MJ
    Lancet; 1989 Jan; 1(8630):167. PubMed ID: 2563088
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy.
    de Silva M; MacArdle B; McGowan M; Hughes E; Stewart J; Neville BG; Johnson AL; Reynolds EH
    Lancet; 1996 Mar; 347(9003):709-13. PubMed ID: 8601999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transient Parkinson syndrome and tremor caused by the use of sodium valproate].
    van der Zwan A
    Ned Tijdschr Geneeskd; 1989 Jun; 133(24):1230-2. PubMed ID: 2501690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticonvulsive pharmacotherapy may aggravate epilepsy course].
    Zenkov LR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):52-4. PubMed ID: 16281381
    [No Abstract]   [Full Text] [Related]  

  • 12. Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.
    Duncan JS; Shorvon SD; Trimble MR
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):924-8. PubMed ID: 3144581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dipropylacetate (sodium valproate) and carbamazepine : a suspicious anticonvulsant combination].
    Lhermitte F; Marteau R; Serdaru M
    Nouv Presse Med; 1978 Nov; 7(41):3780. PubMed ID: 366563
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parkinsonism due to the medication].
    Louter M; Tromp SC
    Ned Tijdschr Geneeskd; 2009; 153():A336. PubMed ID: 19900308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresponsiveness to etretinate during anticonvulsant therapy.
    Mohammed KN
    Dermatology; 1992; 185(1):79. PubMed ID: 1638082
    [No Abstract]   [Full Text] [Related]  

  • 16. Pure red aplasia induced by sodium valproate in a patient with Behçet's syndrome.
    Leccese P; Attolico I; Padula A; Diplomatico A; D'Angelo S; Olivieri I
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):132. PubMed ID: 29148419
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible rapidly progressive dementia with parkinsonism induced by valproate in a patient with systemic lupus erythematosus.
    Sleegers MJ; Beutler JJ; Hardon WJ; Berden JH; Verhave JC; Conemans JM; Hollander DA; Dautzenberg PL; Hoogeveen EK
    J Am Geriatr Soc; 2010 Apr; 58(4):799-801. PubMed ID: 20398172
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug therapy: Valproic acid.
    Koch-Weser J; Browne TR
    N Engl J Med; 1980 Mar; 302(12):661-6. PubMed ID: 6766529
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversible cholestatic hepatitis due to carbamazepine in an adolescent.
    Wadhawan M; Tyagi P; Malhotra V; Sakhuja P; Puri AS
    Indian J Gastroenterol; 2005; 24(4):172-3. PubMed ID: 16204911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate.
    Easterford K; Clough P; Kellett M; Fallon K; Duncan S
    Neurology; 2004 Apr; 62(8):1435-7. PubMed ID: 15111693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.